Asthma biologics: Underuse, overuse, and best use?

Ann Allergy Asthma Immunol. 2019 Apr;122(4):358-359. doi: 10.1016/j.anai.2018.12.016. Epub 2018 Dec 19.

Authors

Matthew A Rank¹, John J Oppenheimer²

Affiliations

¹ Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic in Arizona, Scottsdale, Arizona; Division of Pulmonology, Phoenix Children's Hospital, Phoenix, Arizona. Electronic address: rank.matthew@mayo.edu.
² Department of Medicine, Rutgers New Jersey Medical School, Morristown, New Jersey.

PMID: 30578858
DOI: 10.1016/j.anai.2018.12.016

No abstract available

MeSH terms

Anti-Asthmatic Agents / therapeutic use*
Asthma / drug therapy*
Biological Products / therapeutic use*
Drug Utilization
Humans
Practice Patterns, Physicians'

Substances

Anti-Asthmatic Agents
Biological Products